first vaccination – Page 9 – Communicable Diseases Research

Immunogenicity of BNT162b2 mRNA COVID-19 Vaccine in Patients with Cardiovascular Disease

Article

Published on 2021-11-242022-10-30
Journal: Journal of Clinical Medicine [Category] COVID-19,

Lymphocytopenia and Anti-CD38 Directed Treatment Impact the Serological SARS-CoV-2 Response after Prime Boost Vaccination in Patients with Multiple Myeloma

Article

Published on 2021-11-242022-10-30
Journal: Journal of Clinical Medicine [Category] COVID-19,

[키워드] age Analysis analyzed anti-CD38 anti-CD38-directed therapy anti-SARS-CoV-2 blood sample CD19+ CD19+ B lymphocytes control group correlated disorder Effectiveness eight Factor first vaccination healthy control healthy subjects Heterologous Impact less majority Multiple Multiple myeloma Myeloma Patient patients positive Predictive prevention of COVID-19 Quantitative RBD response responses SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 spike protein antibodies SARS-CoV-2 vaccination SARS-CoV-2 vaccine SARS-CoV-2 vaccines serological serological response shown significantly suggested therapy threshold Treatment vaccination Vaccinations were assessed
[DOI] 10.3390/jcm10235499 PMC 바로가기 [Article Type] Article

Evaluation of Humoral Immune Response after SARS-CoV-2 Vaccination Using Two Binding Antibody Assays and a Neutralizing Antibody Assay

2개의 결합 항체 분석 및 중화 항체 분석을 사용한 SARS-CoV-2 백신 접종 후 체액 면역 반응의 평가

Research Article

Published on 2021-11-242022-09-12
Journal: Microbiology Spectrum [Category] MERS, SARS, 진단, 치료기술,

[키워드] Abbott Abbott Laboratories Abbott SARS-CoV-2 IgG acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Administered antibody Antibody assays Antibody detection automated BNT162b2 ChAdOx1 ChAdOx1 nCoV-19 ChAdOx1 nCoV-19 vaccine collected concordance rate coronavirus coronavirus disease Coronavirus disease 2019 correlation COVID-19 Cutoff demonstrated elicited evaluate first vaccination Genscript Healthcare Diagnostics humoral humoral immune response Humoral response humoral responses IgG Inc. indicated Ireland mitigate Multiple nCoV neutralization test Neutralizing antibodies neutralizing antibody of BNT162b2 pandemic predict Quantitative quantitative value quantitative values response robust SARS-CoV-2 SARS-CoV-2 IgG SARS-CoV-2 neutralization second vaccination seropositive serum sample serum samples severe acute respiratory syndrome Coronavirus Siemen Siemens Sligo suggested U/mL USA Vaccinations Vaccine Vaccines venous blood virus neutralization test was obtained
[DOI] 10.1128/Spectrum.01202-21 PMC 바로가기 [Article Type] Research Article

Comparison of the Results of Five SARS-CoV-2 Antibody Assays before and after the First and Second ChAdOx1 nCoV-19 Vaccinations among Health Care Workers: a Prospective Multicenter Study

의료 종사자의 1차 및 2차 ChAdOx1 nCoV-19 백신 접종 전후 5건의 SARS-CoV-2 항체 분석 결과 비교: 전향적 다기관 연구

Multicenter Study

Published on 2021-11-182022-09-12
Journal: Journal of Clinical Microbiology [Category] MERS, SARS, 진단,

First Report of Two Cases of Löfgren’s Syndrome after SARS-CoV-2 Vaccination-Coincidence or Causality?

Case Report

Published on 2021-11-112022-10-28
Journal: Vaccines [Category] COVID-19,

COVID-19 mRNA Vaccination in Lactation: Assessment of Adverse Events and Vaccine Related Antibodies in Mother-Infant Dyads

수유에서의 Covid-19 mRNA 백신 접종 : 마시어-영향 다이어드에서의 부작용 및 백신 관련 항체의 평가

Immunology

Published on 2021-11-032022-08-13
Journal: Frontiers in Immunology [Category] MERS, SARS, 임상,

[키워드] addition Adverse adverse event age anti-RBD anti-SARS-CoV-2 antibody anti-SARS-CoV-2 IgG anti-SARS-CoV-2 IgG antibodies antibodies antibody assessment automated Blood blood sample Blood samples BNT162b2 Breastfeeding Cohort collected COVID-19 COVID-19 mRNA Vaccination COVID-19 mRNA vaccine diagnosed with COVID-19 dose dyad ELISA first vaccination generate human milk IgA IgA level IgG antibodies IgG antibody IgM immune response immune responses immunoassay individual Infant Infants lactating lactation maternal plasma milk mother mRNA mRNA vaccine mRNA vaccines mRNA-1273 mRNA-based vaccine mRNA-based vaccines passive immunity PEGylated protein PEGylated proteins plasma prospective cohort Pylon 3D Questionnaires reported Result robust SARS-CoV-2 severe adverse event severe adverse events significant level significantly increased study period subset Symptom the vaccine transfer vaccination were assessed were measured
[DOI] 10.3389/fimmu.2021.777103 PMC 바로가기 [Article Type] Immunology

COVID-19 Breakthrough Infections and Transmission Risk: Real-World Data Analyses from Germany’s Largest Public Health Department (Cologne)

Article

Published on 2021-11-022022-10-28
Journal: Vaccines [Category] COVID-19,

Myocarditis and pericarditis in association with COVID-19 mRNA-vaccination: cases from a regional pharmacovigilance centre

Pharmacovigilance

Published on 2021-10-302022-10-31
Journal: Global Cardiology Science & Practice [Category] COVID-19,

Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients

Research

Published on 2021-10-242022-10-29
Journal: Journal of Hematology & Oncology [Category] COVID-19,

[키워드] administration Adults affecting Allogeneic Analysis anti-RBD binding antibody binding domain BNT162b2 BNT162b2 mRNA vaccine CD4 Cell chronic chronic GVHD comparable correlated COVID-19 Cytometry cytometry analysis detectable Factor first vaccination Flow follicular GVHD healthy help helper T cell Hematopoietic cell transplantation identify immunization indicated marker memory B cell mRNA vaccination mRNA vaccine multivariate analyses Neutralizing Neutralizing antibody response Patient patients peripheral blood cell plasmacytoid dendritic cells postvaccination predictor RBD recipient reduced Registered response responses Result risk SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 receptor significantly lower Stem cell transplantation supplementary material Switched B cells T cell T-SNE therapy vaccination Vaccine was performed were assessed wild type
[DOI] 10.1186/s13045-021-01190-3 PMC 바로가기 [Article Type] Research

Use of Quantitative Dried Blood Spots to Evaluate the Post-Vaccination Level of Neutralizing Antibodies against SARS-CoV-2

Article

Published on 2021-10-222022-10-29
Journal: International Review of Cell and Molecular Biology [Category] COVID-19,

[키워드] anti-S anti-S antibody Anti-SARS-CoV-2 S antibodies antibody Blood blood sample carried Clinical studies Cohort Combination composed COVID-19 infection COVID-19 pandemic determine dose Elecsy first vaccination Frequency had no Immune status immunoassay Immunoglobulin individuals information investigated Level limit neutralizing antibodies detection neutralizing antibody Patient peaked persistence Pfizer plasma Population populations produced progression PROTECT Protein Quantitative quantitative dried blood spots random Roche SARS-CoV-2 second dose serum/plasma spot stimulated subject subjects vaccination vaccination against SARS-CoV-2 Vaccine venous viral spike Volunteer
[DOI] 10.3390/life11111125 PMC 바로가기 [Article Type] Article